| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/04/12 | 00 : 17 | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2024/04/12 | 00 : 17 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2024/04/12 | 00 : 08 | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2024/04/12 | 00 : 03 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2024/04/04 | 01 : 08 | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2024/04/04 | 01 : 05 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2024/04/04 | 01 : 04 | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2024/04/04 | 01 : 01 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/11/01 | 23 : 44 | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/11/01 | 23 : 43 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/11/01 | 23 : 43 | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/11/01 | 23 : 40 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/31 | 21 : 00 | PR Newswire (US) | OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 02 : 34 | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 02 : 33 | PR Newswire (Canada) | IIROC Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 02 : 18 | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 02 : 17 | PR Newswire (Canada) | IIROC Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 01 : 47 | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 01 : 46 | PR Newswire (Canada) | IIROC Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 01 : 44 | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 01 : 43 | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 01 : 43 | PR Newswire (Canada) | ttIIROC Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/18 | 01 : 41 | PR Newswire (Canada) | IIROC Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/03 | 19 : 58 | PR Newswire (Canada) | RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across Canada | TSX:BHC | Bausch Health Companies Inc |
| 2023/05/03 | 19 : 58 | PR Newswire (Canada) | RYALTRIS(MD), une nouvelle association sous ordonnance en pulvérisateur nasal pour la rhinite allergique saisonnière (RAS) d'intensité modérée à grave, est maintenant disponible partout au Canada | TSX:BHC | Bausch Health Companies Inc |
| 2022/12/22 | 20 : 59 | PR Newswire (Canada) | First tazarotene lotion treatment for acne vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plans | TSX:BHC | Bausch Health Companies Inc |
| 2022/12/22 | 20 : 59 | PR Newswire (Canada) | ARAZLOMC (lotion de tazarotène, 0,045 %), la première lotion à base de tazarotène indiquée pour le traitement de l'acné vulgaire, est maintenant offerte aux patients du Québec, de l'Ontario, de l'Alberta et de la Saskatchewan dans le cadre des régi | TSX:BHC | Bausch Health Companies Inc |
| 2022/11/18 | 03 : 08 | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2022/11/18 | 03 : 06 | PR Newswire (Canada) | IIROC Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
| 2022/11/18 | 03 : 04 | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |